Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × Low-grade Glioma × tovorafenib × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Not yet recruiting 1 Completed 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Melanoma 3 Low-grade Glioma 2 Pancreatic Neoplasms 1 Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1 Advanced Nonhematologic Malignancies 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07441707 2026-03-02

A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults With Brain Tumours

Ipsen

Phase 1 Not yet recruiting

Low-grade Glioma

NCT03429803 2026-02-19

DAY101 In Gliomas and Other Tumors

Dana-Farber Cancer Institute

Phase 1 Completed

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡